SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus - Covid 19 Information Sharing Forum -- Ignore unavailable to you. Want to Upgrade?

To: Investor2 who wrote (2011)7/28/2021 6:57:10 PM
From: TimF  Respond to of 5955
 
Even 39 percent is useful. (But indeed in many ways not enough). With additional utility from reducing more servere cases.

The data I've seen seems to suggest the delta variant is the best at spreading but the beta variant is best at "getting past" the vaccines.

And assuming that's accurate presumably its the lowest of any of the vaccines against any of the variants.

Some more data here - blogs.sciencemag.org



To: Investor2 who wrote (2011)7/29/2021 3:08:32 PM
From: J_F_Shepard  Read Replies (1) | Respond to of 5955
 
I saw one study described on TV this morning where the efficacy of one of the vaccines went down to 39% against the delta variant.
Sounds interesting......want to share the source????


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News